The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Malykhin F.Т.

Stavropol State Medical University Ministry of Health of Russia, Stavropol, Russia

Kostornaya I.V.

Stavropol State Medical University Ministry of Health of Russia, Stavropol, Russia

Morphological changes in the respiratory organs in chronic obstructive pulmonary disease

Authors:

Malykhin F.Т., Kostornaya I.V.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2016;78(1): 42‑50

DOI: 10.17116/patol201678142-50

Read: 9505 times

Contact the author
Table of contents

MORPHOLOGICAL CHANGES IN THE RESPIRATORY ORGANS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
MORPHOLOGICAL CHANGES IN THE RESPIRATORY ORGANS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

To cite this article:

Malykhin FТ, Kostornaya IV. Morphological changes in the respiratory organs in chronic obstructive pulmonary disease. Russian Journal of Archive of Pathology. 2016;78(1):42‑50. (In Russ.)
https://doi.org/10.17116/patol201678142-50

Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Chro­nic obstructive pulmonary disease (COPD 2024). Clinical guidelines (short version). Journal of Respiratory Medi­cine. 2025;(2):5-16
Toba­cco smoking as a factor in the deve­lopment of COPD and pulmonary tube­rculosis. Journal of Respiratory Medi­cine. 2025;(2):45-50
Rese­rves for redu­cing exacerbations in patients with chro­nic obstructive pulmonary disease at a large indu­strial ente­rprise. Journal of Respiratory Medi­cine. 2025;(2):66-70
Prognostic factors for progression and risk chro­nic obstructive pulmonary disease adve­rse outcomes. Journal of Respiratory Medi­cine. 2025;(2):71-78
Digi­tal technologies for outpatient mana­gement of patients with chro­nic obstructive pulmonary disease: oppo­rtunities to reduce the burden of the disease. Russian Journal of Preventive Medi­cine. 2025;(9):134-139
Clinical and patient-reported outcomes of triple therapy (budesonide/glycopyrronium bromide/formoterol) in chro­nic obstructive pulmonary disease: resu­lts of the obse­rvational MINE­RVA study. Journal of Respiratory Medi­cine. 2025;(3):19-26
Clinical markers of inflammation and myocardial remo­deling in patients with chro­nic obstructive pulmonary diseases and chro­nic heart failure. Russian Journal of Preventive Medi­cine. 2025;(11):72-78
Clinical and instrumental characteristics of chro­nic obstructive pulmonary disease in combination with bronchial asthma. Journal of Respiratory Medi­cine. 2025;(4):34-40
Cough-syncope syndrome in a patient with severe exacerbation of COPD. (A clinical case). Journal of Respiratory Medi­cine. 2025;(4):59-62
Effi­cacy of enha­nced exte­rnal counterpulsation in patients with chro­nic obstructive pulmonary disease and bronchial asthma: a pilot study. Russian Journal of Preventive Medi­cine. 2025;(12):89-96
Abstract:

The basis for airway remodeling in patients with chronic obstructive pulmonary disease (COPD) is tissue changes contributing to thickening of the walls of the airway and its obstruction. As the disease becomes severer, there are increases in mucosal metaplasia, submucosal hypertrophy, peribronchial fibrosis, and airway smooth muscle mass. Drug therapy for COPD does not virtually lead to regression of airway obstruction, except when eosinophilia is present.

Keywords:

chronic obstructive pulmonary disease
morphological changes
remodeling

Authors:

Malykhin F.Т.

Stavropol State Medical University Ministry of Health of Russia, Stavropol, Russia

Kostornaya I.V.

Stavropol State Medical University Ministry of Health of Russia, Stavropol, Russia

Close metadata

References:

  1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2015). Available at: http://www.goldcopd.org›uploads/users/files/GOLD...2015.pdf. Accessed June 21, 2015.
  2. Global'naya strategiya diagnostiki, lecheniya i profilaktiki khronicheskoi obstruktivnoi bolezni legkikh (peresmotr 2014 g.). Per. s angl. pod red. Belevskogo A.S. M.: Rossiiskoe respublikanskoe obshchestvo; 2015.
  3. Donnelly LE, Barnes PJ. Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease. Trends Pharmacol Sci. 2006;27:546-553.  https://doi.org/10.1016/j.tips.2006.08.001
  4. Gamble E, Grootendorst DC, Hattotuwa K, O’Shaughnessy T, Ram FS, Qiu Y et al. Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis. Eur Respir J. 2007;30:467-471.  https://doi.org/10.1183/09031936.00013006
  5. Kosheleva O.K., Zairat'yants O.V., Chernyaev A.L., Malyavin A.G. Sovremennye predstavleniya o khronicheskoi obstruktivnoi bolezni legkikh i senil'nykh legkikh. Arkhiv patologii. 2013;75(4):38-40.
  6. Chernyaev A.L., Samsonova M.V. Patologicheskaya anatomiya legkikh. Atlas. 2-e izd. M.: Atmosfera; 2011.
  7. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22:672-688.  https://doi.org/10.1183/09031936.03.00040703
  8. Rahman I. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem Biophys. 2005;43:167-188.  https://doi.org/10.1385/cbb:43:1:167
  9. Malhotra D, Thimmulappa R, Navas-Acien A, Sandford A, Elliott M, Singh A et al. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med. 2008;178:592-604.  https://doi.org/10.1164/rccm.200803-380oc
  10. Izakson E. O patologoanatomicheskikh izmeneniyakh legochnykh sosudov pri emfizematoznykh protsessakh v legkikh: Dis. ... d-ra meditsiny. SPb.; 1870. (Opublikovana v zhurnale Pul'monologiya. 2005;4:41-52).
  11. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2645-2653. https://doi.org/10.1056/nejmoa032158
  12. Thurlbeck WM, William JL. Thurlbeck’s chronic airflow obstruction. 2nd ed. Hamilton: B.C. Decker; 1999.
  13. Chernyaev A.L., Samsonova M.V., Loshchilov Yu.A. Khronicheskaya obstruktivnaya bolezn' legkikh. V kn.: Patologicheskaya anatomiya: natsional'noe rukovodstvo. Pod red. Pal'tseva M.A., Kakturskogo L.V., Zairat'yantsa O.V. M.: GEOTAR-Media; 2013:395-400.
  14. van den Berge M, Polosa R, Kerstjens HAM, Postma DS. The role of endogenous and exogenous AMP in asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2004;114:737-746.  https://doi.org/10.1016/j.jaci.2004.05.071
  15. Sutherland ER. Outpatient treatment of chronic obstructive pulmonary disease: comparisons with asthma. J Allergy Clin Immunol. 2004;114:715-724.  https://doi.org/10.1016/j.jaci.2004.07.044
  16. Hirst SJ, Martin JG, Bonacci JV, Chan V, Fixman ED, Hamid QA et al. Proliferative aspects of airway smooth muscle. J Allergy Clin Immunol. 2004;114:2-17.  https://doi.org/10.1016/j.jaci.2004.04.039
  17. Hamid Q, Cosio M, Lim S. Inflammation and remodeling in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2004;114:1479-1481. https://doi.org/10.1016/j.jaci.2004. 10.1016
  18. Kop'eva T.N., Barmina G.V., Grobova O.M., Voronina L.M. Mestnye mekhanizmy zashchity pri khronicheskom zabolevanii v legkikh. Arkhiv patologii. 1992;53(9):5-12.
  19. Mio T, Romberger DJ, Thompson AB, Robbins RA, Heires A, Rennard SI. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med. 1997;155:1770-1776. https://doi.org/10.1164/ajrccm.155.5.9154890
  20. Masubuchi T, Koyama S, Sato E, Takamizawa A, Kubo K, Sekiguchi M et al. Smoke extract stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Pathol. 1998;153:1903-1912. https://doi.org/10.1016/s0002-9440(10)65704-5
  21. Esipova I.K., Alekseevskikh Yu.G. Strukturno-funktsional'nye osobennosti krupnykh i melkikh bronkhov i razlichiya voznikayushchikh v nikh vospalitel'nykh reaktsii. Arkhiv patologii. 1994;55(4):6-9.
  22. Reid LM. Chronic obstructive pulmonary diseases. In: Fishman AP, ed. Pulmonary diseases and disorders. 2nd ed. New York: McGraw-Hill; 1988:1247-1272.
  23. Laitinen LA, Laitinen A. Mucosal inflammation and bronchial hyperreactivity. Eur Respir J. 1988;1:488-489.
  24. Lundgren R, Soderberg M, Horstedt P, Stenling R. Morphological studies of bronchial biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J. 1988;1:883-889.
  25. Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G et al. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature. 2003;422:169-173.  https://doi.org/10.1038/nature01413
  26. Chanez P, Vignola AM, O’Shaugnessy T, Enander I, Li D, Jeffery PK et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med. 1997;155:1529-1534. https://doi.org/10.1164/ajrccm.155.5.9154853
  27. Wright JL, Petty T, Thurlbeck WM. Analysis of the structure of the muscular pulmonary arteries in patients with pulmonary hypertension and COPD: National Institutes of Health nocturnal oxygen therapy trial. Lung. 1992;170:109-124.  https://doi.org/10.1007/bf00175982
  28. Magee F, Wright JL, Wiggs BR, Pare PD, Hogg JC. Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax. 1988;43:183-189.  https://doi.org/10.1136/thx.43.3.183
  29. MacNee W. Right heart function in COPD. Semin Respir Crit Care Med. 2010;31:295-312.  https://doi.org/10.1055/s-0030-1254070
  30. Dunnill MS, Massarella GR, Anderson JA. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax. 1969;24:176-179.  https://doi.org/10.1136/thx.24.2.176
  31. Peto R, Speizer FE, Cochrane AL, Moore F, Fletcher CM, Tinker CM et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease: results from 20 years of prospective observation. Am Rev Respir Dis. 1983;128:491-500.
  32. Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 1996;153:1530-1535. https://doi.org/10.1164/ajrccm.153.5.8630597
  33. Aikawa T, Shimura S, Sasaki H, Takishima T, Yaegashi H, Takahashi T. Morphometric analysis of intraluminal mucus in airways in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1989;140(2):477-482.  https://doi.org/10.1164/ajrccm/140.2.477
  34. Nagai A, West WW, Thurlbeck WM. The National Institutes of Health Intermittent Positive-Pressure Breathing trial: pathology studies: II. Correlation between morphologic findings, clinical findings, and evidence of expiratory air-flow obstruction. Am Rev Respir Dis. 1985;132:946-953.
  35. Saetta M, Turato G, Baraldo S, Zanin A, Braccioni F, Mapp CE et al. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med. 2000;161(3, Pt 1):1016-1021. https://doi.org/10.1164/ajrccm.161.3.9907080
  36. Sommerhoff CP, Nadel JA, Basbaum CB, Caughey GH. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Invest. 1990;85:682-689.  https://doi.org/10.1172/jci114492
  37. Grobova O.M., Kop'eva T.N., Makarova O.V., Borisova O.M., Dykhanov I.I., Makarova S.A. Tsitologicheskaya kharakteristika bronkhoal'veolyarnykh smyvov pri khronicheskom bronkhite. Problemy tuberkuleza. 1989;12:7-11. 
  38. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL et al. COPD phenotypes: The future of COPD. Am J Respir Crit Care Med. 2010;182:598-604.  https://doi.org/10.1164/rccm.200912-1843cc
  39. Garcia-Aymerich J, Serra I, Gomez FP, Farrero E, Balcells E, Rodríguez DA et al. Physical activity and clinical and functional status in COPD. Chest. 2009;136(1):62-70. https://doi.org/10.1378/chest.08-2532
  40. Cosio M, Ghezzo H, Hogg JC, Corbin R, Loveland M, Dosman J et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med. 1978;298:1277-1281. https://doi.org/10.1056/nejm197806082982303
  41. van Straaten JF, Coers W, Noordhoek JA, Huitema S, Flipsen JT, Kauffman HF et al. Proteoglycan changes in the extracellular matrix of lung tissue from patients with pulmonary emphysema. Mod Pathol. 1999;12:697-705.
  42. Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med. 2003;167:1360-1368. https://doi.org/10.1164/rccm.200209-1030oc
  43. Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax. 1998;53:2129-136.  https://doi.org/10.1136/thx.53.2.129
  44. Jarai G, Sukkar M, Garrett S, Duroudier N, Westwick J, Adcock I et al. Effects of interleukin-1beta, interleukin-13 and transforming growth factor-beta on gene expression in human airway smooth muscle using gene microarrays. Eur J Pharmacol. 2004;497:255-265.  https://doi.org/10.1016/j.ejphar.2004.06.055
  45. Howarth PH, Knox AJ, Amrani Y, Tliba O, Panettieri RA Jr, Johnson M. Synthetic responses in airway smooth muscle. J Allergy Clin Immunol. 2004;114:32-50.  https://doi.org/10.1016/j.jaci.2004.04.041
  46. Tiddens HA, Pare PD, Hogg JC, Hop WC, Lambert R, De Jongste JC. Cartilaginous airway dimensions and airflow obstruction in human lungs. Am J Respir Crit Care Med. 1995;152:260-266.  https://doi.org/10.1164/ajrccm.152.1.7599833
  47. Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, Hogg JC. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1993;148:1220-1225. https://doi.org/10.1164/ajrccm/148.5.1220
  48. Chung KF. The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease. Symposium: the science of COPD: opportunities for combination therapy. Proc Am Thorac Soc. 2005;2(4):347-354.  https://doi.org/10.1513/pats.200504-028sr
  49. Lamb D. Chronic obstructive pulmonary disease: pathology. In: Brewis RAL, Gibson GJ, Geddes DM, eds. Respiratory medicine. London: Bailliere Tindall; 1990;497-507. 
  50. Kim WD, Eidelman DH, Izquierdo JL, Ghezzo H, Saetta MP, Cosio MG. Centrilobular and panlobular emphysema in smokers. Two distinct morphologic and functional entities. Am Rev Respir Dis. 1991;144(6):1385-1390. https://doi.org/10.1164/ajrccm/144.6.1385
  51. Finkelstein R, Ma HD, Ghezzo H, Whittaker K, Fraser RS, Cosio MG. Morphometry of small airways in smokers and its relationship to emphysema type and hyperresponsiveness. Am J Respir Crit Care Med. 1995;152:267-276.  https://doi.org/10.1164/ajrccm.152.1.7599834
  52. Saetta M, Finkelstein R, Cosio MG. Morphological and cellular basis for airflow limitation in smokers. Eur Respir J. 1994;7:150-1515. https://doi.org/10.1183/09031936.94.07081505
  53. Saetta M, Shiner RJ, Angus GE, Kim WD, Wang NS, King M et al. Destructive index: a measurement of lung parenchymal destruction in smokers. Am Rev Respir Dis. 1985;131:764-769. 
  54. Esipova I.K. Patologicheskaya anatomiya legkikh. M.: Meditsina; 1976.
  55. Hale KA, Ewing SL, Gosnell BA, Niewoehner DE. Lung disease in long-term cigarette smokers with and without chronic air-flow obstruction. AmRev Respir Dis. 1984;130:716-721.
  56. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278:1355-1360. https://doi.org/10.1056/nejm196806202782501
  57. Bosken CH, Wiggs BR, Pare PD, Hogg JC. Small airway dimensions in smokers with obstruction to airflow. Am Rev Respir Dis. 1990;142:563-570.  https://doi.org/10.1164/ajrccm/142.3.563
  58. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med. 1996;153:1802-1811. https://doi.org/10.1164/ajrccm.153.6.8665038
  59. Chuchalin A.G., red. Khronicheskaya obstruktivnaya bolezn' legkikh. Federal'naya programma. 2-e izd. Leshchenko I.V., Ovcharenko S.I., Shmelev E.I., sost. M.; 2004.
  60. Chanez P, Vignola AM, O’Shaugnessy T, Enander I, Li D, Jeffery PK et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med. 1997;155:1529-1534. https://doi.org/10.1164/ajrccm.155.5.9154853
  61. Malykhin F.T. Pokazateli β-adrenoretseptsii u pozhilykh bol'nykh s obostreniem khronicheskogo obstruktivnogo bronkhita. Vestnik Rossiiskogo universiteta druzhby narodov. Seriya: Meditsina. 2012;1:43-45.
  62. Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial. Lancet. 2003;361:449-456. https://doi.org/10.1016/s0140-6736(03)12459-2
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.